Literature DB >> 10861675

New form of idiopathic osteolysis: nodulosis, arthropathy and osteolysis (NAO) syndrome.

S M Al-Mayouf1, M Majeed, C Hugosson, S Bahabri.   

Abstract

We describe 10 patients (6 females and 4 males) from 6 unrelated families with an autosomal recessive disease characterized by simultaneous presentation of nodulosis, arthropathy and osteolysis. They were followed up regularly at King Faisal Specialist Hospital and Research Center in Saudi Arabia for clinical evaluation, serial blood work-up, and evaluating radiological changes. Nodulosis and arthropathy were the clinical criteria for inclusion in this study, and the ten patients fulfilled these criteria. All patients had nodulosis and distal arthropathy. Eight patients (80%) presented with deformed hands and four (40%) with painful hands. All patients had parents who were first cousins and three families had more than one affected child, the finding suggesting autosomal recessive inheritance. Osteopenia and undertubulation of bones distally more than proximally, and upper limbs affected more often than lower limbs, were found in all patients. Osteolysis was seen in carpal and tarsal bones. Other common findings were sclerotic cranial sutures, brachycephaly, and broad medial clavicles. This novel phenotype should be considered in the differential diagnosis of chronic arthritis. Familial arthropathies are more often seen in communities where interfamilial marriage is common. Such a collection of patients is ideal for homozygosity mapping of the disease locus. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10861675     DOI: 10.1002/1096-8628(20000703)93:1<5::aid-ajmg2>3.0.co;2-y

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  12 in total

1.  Cyclic intravenous pamidronate treatment in children with nodulosis, arthropathy and osteolysis syndrome.

Authors:  S M Al-Mayouf; S M Madi; B S Bin-Abbas
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

2.  Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth.

Authors:  Rebecca A Mosig; Oonagh Dowling; Analisa DiFeo; Maria Celeste M Ramirez; Ian C Parker; Etsuko Abe; Janane Diouri; Aida Al Aqeel; James D Wylie; Samantha A Oblander; Joseph Madri; Paolo Bianco; Suneel S Apte; Mone Zaidi; Stephen B Doty; Robert J Majeska; Mitchell B Schaffler; John A Martignetti
Journal:  Hum Mol Genet       Date:  2007-03-30       Impact factor: 6.150

3.  Functional characterisation of a novel mutation affecting the catalytic domain of MMP2 in siblings with multicentric osteolysis, nodulosis and arthropathy.

Authors:  Jacopo Azzollini; Davide Rovina; Cristina Gervasini; Ilaria Parenti; Alessia Fratoni; Maria Vittoria Cubellis; Amilcare Cerri; Luca Pietrogrande; Lidia Larizza
Journal:  J Hum Genet       Date:  2014-10-02       Impact factor: 3.172

Review 4.  Multicentric osteolysis with nodulosis and arthropathy (MONA) with cardiac malformation, mimicking polyarticular juvenile idiopathic arthritis: case report and literature review.

Authors:  Filip Christian Castberg; Susanne Kjaergaard; Rebecca A Mosig; Mollie Lobl; Chiara Martignetti; John A Martignetti; Charlotte Myrup; Marek Zak
Journal:  Eur J Pediatr       Date:  2013-07-31       Impact factor: 3.183

5.  Inherited multicentric osteolysis with carpal-tarsal localisation mimicking juvenile idiopathic arthritis.

Authors:  Marianne R Faber; René Verlaak; Theo J W Fiselier; Ben C J Hamel; Marcel J A M Franssen; G Peter J M Gerrits
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

6.  A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects.

Authors:  Beyhan Tuysuz; Rebecca Mosig; Gürkan Altun; Selim Sancak; Marc J Glucksman; John A Martignetti
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

7.  Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development.

Authors:  Mikala Egeblad; H-C Jennifer Shen; Danielle J Behonick; Lisa Wilmes; Alexandra Eichten; Lidiya V Korets; Farrah Kheradmand; Zena Werb; Lisa M Coussens
Journal:  Dev Dyn       Date:  2007-06       Impact factor: 3.780

Review 8.  Patient with mutation in the matrix metalloproteinase 2 (MMP2) gene - a case report and review of the literature.

Authors:  Alka V Ekbote; Sumita Danda; Andreas Zankl; Kausik Mandal; Tina Maguire; Kobus Ungerer
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014

Review 9.  Erosive arthropathy with osteolysis as a typical feature in polyfibromatosis syndrome: a case report and a review of the literature.

Authors:  Seong-Kyu Kim; Hyung Joon Kim; Young Hwan Lee; Kyung Jin Suh; Sung-Hoon Park; Jung-Yoon Choe
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

10.  Multicentric Osteolysis, Nodulosis, and Arthropathy in two unrelated children with matrix metalloproteinase 2 variants: Genetic-skeletal correlations.

Authors:  Hanan Elsebaie; Mohamed Abdelhafiz Mansour; Solaf M Elsayed; Shady Mahmoud; Tamer A El-Sobky
Journal:  Bone Rep       Date:  2021-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.